CL2013000223A1 - Uso de hmgb1 como marcador biologico de afecciones intestinales inflamatorias , metodo no invasivo para deteccion en muestras fecales y kit para su realizacion. - Google Patents
Uso de hmgb1 como marcador biologico de afecciones intestinales inflamatorias , metodo no invasivo para deteccion en muestras fecales y kit para su realizacion.Info
- Publication number
- CL2013000223A1 CL2013000223A1 CL2013000223A CL2013000223A CL2013000223A1 CL 2013000223 A1 CL2013000223 A1 CL 2013000223A1 CL 2013000223 A CL2013000223 A CL 2013000223A CL 2013000223 A CL2013000223 A CL 2013000223A CL 2013000223 A1 CL2013000223 A1 CL 2013000223A1
- Authority
- CL
- Chile
- Prior art keywords
- hmgb1
- kit
- realization
- detection
- inflammatory bowel
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2010A000442A IT1406051B1 (it) | 2010-08-05 | 2010-08-05 | Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013000223A1 true CL2013000223A1 (es) | 2014-03-28 |
Family
ID=43739596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013000223A CL2013000223A1 (es) | 2010-08-05 | 2013-01-23 | Uso de hmgb1 como marcador biologico de afecciones intestinales inflamatorias , metodo no invasivo para deteccion en muestras fecales y kit para su realizacion. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20130137123A1 (https=) |
| EP (1) | EP2601525A1 (https=) |
| JP (1) | JP2013534313A (https=) |
| CN (1) | CN103069276A (https=) |
| AU (1) | AU2011287193B2 (https=) |
| BR (1) | BR112013002145A2 (https=) |
| CA (1) | CA2807107C (https=) |
| CL (1) | CL2013000223A1 (https=) |
| EA (1) | EA201390197A1 (https=) |
| IL (1) | IL223845A (https=) |
| IT (1) | IT1406051B1 (https=) |
| MX (1) | MX2013001327A (https=) |
| PE (1) | PE20131062A1 (https=) |
| WO (1) | WO2012017466A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015067913A1 (en) | 2013-11-07 | 2015-05-14 | Diagnodus Limited | Biomarkers |
| DK2968443T3 (da) | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| PT3143037T (pt) | 2014-05-16 | 2021-09-24 | Protagonist Therapeutics Inc | Antagonistas peptídicos tioéter de integrina alfa4beta7 |
| US9624268B2 (en) | 2014-07-17 | 2017-04-18 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| US20200064357A1 (en) * | 2016-11-09 | 2020-02-27 | Protagonist Therapeutics, Inc. | Methods for determining and monitoring gastrointestinal inflammation |
| PL3622082T3 (pl) | 2017-05-12 | 2023-07-31 | Evonik Operations Gmbh | Sposób wykrywania chorób wywołanych przez C. perfringens w stadzie ptaków |
| IT201700083044A1 (it) | 2017-07-20 | 2019-01-20 | Laura Stronati | “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” |
| IT201700083055A1 (it) | 2017-07-20 | 2019-01-20 | Laura Stronati | “uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” |
| EP3749345A4 (en) | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| US12031991B2 (en) * | 2018-03-02 | 2024-07-09 | Evonik Operations Gmbh | In vitro method for detecting intestinal barrier failure in animals |
| CN109030817A (zh) * | 2018-07-04 | 2018-12-18 | 长沙都正医学检验有限责任公司 | Hmgb1检测试剂盒及其制备方法 |
| TW202019948A (zh) | 2018-07-12 | 2020-06-01 | 美商領導醫療有限公司 | 介白素-23受體之肽抑制劑及其治療發炎疾病之用途 |
| DK3894863T3 (en) | 2018-12-14 | 2023-02-20 | Evonik Operations Gmbh | In vitro-fremgangsmåde til påvisning af aviær intestinal dysbiose |
| US11684653B2 (en) * | 2019-03-06 | 2023-06-27 | The Cleveland Clinic Foundation | Compositions and method for reducing virulence of microorganisms |
| HRP20250769T1 (hr) | 2020-01-15 | 2025-08-29 | Janssen Biotech, Inc. | Peptidni inhibitori receptora za interleukin-23 i njihova uporaba u liječenju upalnih bolesti |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| WO2023288019A2 (en) | 2021-07-14 | 2023-01-19 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of interleukin-23 receptor |
| CN116973572B (zh) * | 2023-06-02 | 2025-03-07 | 东南大学附属中大医院 | 基于血、粪便铁蛋白检测评估肠屏障损伤严重程度的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822078B2 (en) * | 1996-07-17 | 2004-11-23 | Kaneka Corp. | Diagnostic drugs for autoimmune diseases |
| US6355623B2 (en) * | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
| US6303321B1 (en) * | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US7700307B2 (en) * | 2003-03-08 | 2010-04-20 | Auvation Limited | Mitochondrial stress-70 protein markers for colorectal cancer |
| US7585504B2 (en) * | 2004-10-22 | 2009-09-08 | Medimmune, Llc | High affinity antibodies against HMGB1 and methods of use thereof |
| US20090297546A1 (en) * | 2006-12-20 | 2009-12-03 | Shino-Test Corporation | Avian-derived antibody capable of binding specifically to human hmgb1, immunological determination method for human hmgb1, and immunological determination reagent for human hmgb1 |
| EA201000131A1 (ru) * | 2007-08-02 | 2010-08-30 | АйЭсЭс ИММЬЮН СИСТЕМ СТИМУЛЕЙШН АБ | Диагностика, определение стадии и мониторинг воспалительного заболевания кишечника |
| US7879553B2 (en) * | 2008-03-14 | 2011-02-01 | Exagen Diagnostics, Inc. | Biomarkers for inflammatory bowel disease and irritable bowel syndrome |
-
2010
- 2010-08-05 IT ITRM2010A000442A patent/IT1406051B1/it active
-
2011
- 2011-08-01 BR BR112013002145A patent/BR112013002145A2/pt not_active IP Right Cessation
- 2011-08-01 WO PCT/IT2011/000276 patent/WO2012017466A1/en not_active Ceased
- 2011-08-01 EP EP11754539.2A patent/EP2601525A1/en not_active Withdrawn
- 2011-08-01 CA CA2807107A patent/CA2807107C/en not_active Expired - Fee Related
- 2011-08-01 MX MX2013001327A patent/MX2013001327A/es unknown
- 2011-08-01 US US13/814,294 patent/US20130137123A1/en not_active Abandoned
- 2011-08-01 JP JP2013522346A patent/JP2013534313A/ja active Pending
- 2011-08-01 CN CN2011800327624A patent/CN103069276A/zh active Pending
- 2011-08-01 EA EA201390197A patent/EA201390197A1/ru unknown
- 2011-08-01 PE PE2013000131A patent/PE20131062A1/es not_active Application Discontinuation
- 2011-08-01 AU AU2011287193A patent/AU2011287193B2/en not_active Ceased
-
2012
- 2012-12-24 IL IL223845A patent/IL223845A/en active IP Right Grant
-
2013
- 2013-01-23 CL CL2013000223A patent/CL2013000223A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011287193B2 (en) | 2015-08-13 |
| WO2012017466A8 (en) | 2013-07-11 |
| EA201390197A1 (ru) | 2013-06-28 |
| JP2013534313A (ja) | 2013-09-02 |
| CN103069276A (zh) | 2013-04-24 |
| AU2011287193A1 (en) | 2013-06-13 |
| ITRM20100442A1 (it) | 2012-02-06 |
| WO2012017466A1 (en) | 2012-02-09 |
| IT1406051B1 (it) | 2014-02-06 |
| MX2013001327A (es) | 2013-03-08 |
| CA2807107C (en) | 2017-01-03 |
| PE20131062A1 (es) | 2013-10-16 |
| CA2807107A1 (en) | 2012-02-09 |
| EP2601525A1 (en) | 2013-06-12 |
| BR112013002145A2 (pt) | 2016-05-24 |
| US20130137123A1 (en) | 2013-05-30 |
| IL223845A (en) | 2016-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2013000223A1 (es) | Uso de hmgb1 como marcador biologico de afecciones intestinales inflamatorias , metodo no invasivo para deteccion en muestras fecales y kit para su realizacion. | |
| IL233096A0 (en) | Ratio based biomarkers and methods of use thereof | |
| IL254144A0 (en) | Methods for reprogramming cells and uses thereof | |
| BRPI0919438A2 (pt) | mistura de poliésteres, e, uso das misturas de poliésteres | |
| BRPI1009420A2 (pt) | axmi-001, axmi-002, axmi-030, e axmi-045; genes de toxina e métodos para seu uso | |
| BRPI1012340A (pt) | proteínas de ligação específica e usos das mesmas | |
| BRPI1012861A2 (pt) | catalisador, e, uso do catalisador | |
| BRPI0819956A2 (pt) | Métodos e aparelhos de nova seleção celular. | |
| BRPI1010774A2 (pt) | método de uso de particulados. | |
| BRPI1014544A8 (pt) | anticorpos anti-il-17f e metodos de uso dos mesmos | |
| BRPI1014843A2 (pt) | dispositivo de medição de urina. | |
| BR112012005736A2 (pt) | di-hidro benzocicloalquiloximetil oxazolapirimidinonas substituídas, preparação e uso das mesmas | |
| BR112012001043A2 (pt) | tinturas fluorescentes e uso das mesmas | |
| BRPI0920891A2 (pt) | misturas de alfa-amilase e métodos para uso das referidas misturas | |
| BRPI1006996A2 (pt) | composição, método e uso | |
| BRPI1007397A2 (pt) | misturas de borrachas, método para a fabricação das misturas de borrachas e seu uso | |
| BRPI0924180A2 (pt) | lacases e métodos de uso das mesmas em baixa temperatura | |
| BRPI0814988A2 (pt) | Hidridização in-situ para detectar marcadores de rna e dna. | |
| BR112012014678A2 (pt) | "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento" | |
| BRPI1013671A2 (pt) | método para o diagnóstico de endometriose e kit de diagnóstico para endometriose | |
| BRPI1010859A2 (pt) | aptâmero para quimase, e uso do mesmo | |
| BR112014012882A2 (pt) | método, anticorpo, polinucleotídeo, célula hospedeira, linhagem celular de hibridoma, uso do anticorpo e kit | |
| BRPI1009460A2 (pt) | domínio de ligação do anticorpo, anticorpo, uso de um domínio de ligação ou anticorpo, método para detectar a presença de células cancerígenas em uma amostra. | |
| BRPI1009257A2 (pt) | antagonista receptor de mineralocorticoide e métodos de uso. | |
| BRPI1011278A2 (pt) | sonda para inseminação artificial, em especial de porcos |